SCHEMBL7302115

SCHEMBL7302115

CCOC(=O)C(Cc1cccc(Cl)c1OC)C(=O)OCC

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
TSHR P16473 2/20 0.42
MAPK1 P28482 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
EPHX2 P34913 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MMP8 P22894 1/20 0.40
KMT2A Q03164 1/20 0.39
NLRP3 Q96P20 1/20 0.39
CASP1 P29466 1/20 0.38
NPC1 O15118 1/20 0.38
RORC P51449 1/20 0.38
NOTUM Q6P988 1/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL491027 0.84 LMNA (0.52) ALDH1A1TSHRMAPK1TDP1L3MBTL1
SCHEMBL2673394 0.83 ALDH1A1 (0.50) ALDH1A1TSHRTDP1EPHX2SMN1; SMN2
SCHEMBL11847066 0.80 POLB (0.42) ALDH1A1TSHRL3MBTL1EPHX2SMN1; SMN2
SCHEMBL31075841 0.79 NLRP3 (0.47) ALDH1A1MAPK1SMN1; SMN2KMT2ANLRP3
SCHEMBL19502670 0.78 MMP8 (0.54) ALDH1A1TSHRTDP1SMN1; SMN2MMP8
SCHEMBL15391734 0.78 MEN1 (0.45) ALDH1A1TSHRMAPK1TDP1L3MBTL1
SCHEMBL7293339 0.77 CYP4F2 (0.56) ALDH1A1SMN1; SMN2NLRP3MAPTGAA
SCHEMBL3344661 0.77 EPHX2 (0.47) ALDH1A1TSHRTDP1EPHX2MMP8
SCHEMBL490730 0.77 ALDH1A1 (0.48) ALDH1A1TSHRTDP1L3MBTL1SMN1; SMN2
SCHEMBL10978584 0.76 GABRA1 (0.41) ALDH1A1L3MBTL1SMN1; SMN2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5444083-A DOPAMINE AGONIST FOR TREATING OR PREVENTION OF HYPERTENSION OR HEART FAILURE EISAI CO., LTD. (JP) 1995-08-22 US disclosed
EP-0381235-B1 PYRROLIDINE COMPOUND AND PHARMACEUTICAL USE Eisai Co., Ltd. (JP) 1993-07-28 EP disclosed
CN-1044652-A Pyrrolidine compound and its pharmaceutical use EISAI CO LTD (JP) 1990-08-15 CN disclosed
EP-0381235-A2 Pyrrolidine compound and pharmaceutical use Eisai Co., Ltd. (JP) 1990-08-08 EP disclosed